US LBM’S JONATHAN GREENE NAMED NEW CHIEF DIGITAL AND TECHNOLOGY OFFICER
National building materials distributer announces new leadership. ATLANTA, March 28, 2025 /PRNewswire/ — US LBM, a leading distributor of specialty building... Read more.
TEN Holdings, Inc. Reports Full Year 2024 Financial Results
LANGHORNE, Pa., March 28, 2025 /PRNewswire/ — TEN Holdings, Inc. (Nasdaq: XHLD) (“TEN Holdings” or the “Company”), a provider of... Read more.
CASEKOO Watering Spring: Spin into Spring Vibes with the MagicStand Pro
LOS ANGELES, March 28, 2025 /PRNewswire/ — CASEKOO is proud to introduce its highly anticipated Spring Collection, a series of phone cases designed to inspire... Read more.
NASA Awards Launch Services Contract for SpaceX Starship
WASHINGTON, March 28, 2025 /PRNewswire/ — NASA has awarded SpaceX of Starbase, Texas, a modification under the NASA Launch Services (NLS) II contract to add... Read more.
Crave Original Series EMPATHIE honoured at Series Mania Festival
Written by Florence Longpré and directed by Guillaume Lonergan, EMPATHIE earns the Audience Award The Crave Original series from Québec premieres on April 10,... Read more.
GigaMedia Announces Fourth-Quarter and Full Year 2024 Financial Results
TAIPEI, March 28, 2025 /PRNewswire/ — GigaMedia Limited (NASDAQ: GIGM) today announced its unaudited financial results for the fourth quarter and full year... Read more.
PRG Welcomes Carl Vogel
Carl Vogel to become Interim CEO focused on accelerating growth NEW YORK, March 28, 2025 /PRNewswire/ — PRG (Production Resource Group), the world’s... Read more.
EpicCyber Announces Partnership with TD SYNNEX to Provide Zscaler Deployment and Value Services
MILL VALLEY, Calif., March 28, 2025 /PRNewswire/ — EpicCyber, a leader in Zscaler deployment and operational services, announces its partnership with TD SYNNEX... Read more.
Globant to Hold its Annual General Meeting of Shareholders on April 30, 2025
LUXEMBOURG, March 28, 2025 /PRNewswire/ — Globant S.A. (NYSE: GLOB) (the “Company“), a digitally native technology services company focused on... Read more.
Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025
LEXINGTON, Mass., March 28, 2025 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an... Read more.